Journal Logo

Poster Session II: Acute myeloid leukemia – Clinical

PS1052 AGE >70 YEARS, HIGH-RISK CYTOGENETICS, SORROR COMORBIDITY SCORE >1 AND BLAST COUNT>40% IN BM ARE RISK FACTORS FOR INDUCTION FAILURE OF STANDARD CHEMOTHERAPY WITH ANTHRACYCLINE AND CYTARABINE IN AML

Pannenbeckers, M.1; Jehn, C.1; Salwender, H.1; Dahmash, F.1; Singh, A.1; Shikova, J.1; Klapproth, A.1; Vierbuchen, M.2; Elmaagacli, A.1

Author Information
doi: 10.1097/01.HS9.0000562504.21650.27
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.